Stem cell transplantation in the context of HIV-how can we cure HIV infection?

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

All HIV target cells are derived from hematopoietic stem cells. More than two decades ago, a hypothesis was postulated that a cure for HIV may be possible by performing a transplant with HIV-resistant hematopoietic stem cells that would allow for an HIV-resistant immune system to arise. HIV-resistant stem cells could be generated by genetically modifying them with gene therapy vectors transferring anti-HIV genes. First attempts of stem cell gene therapy for HIV were carried out in the USA in the 1990s demonstrating safety, but also little efficacy at that time. The first demonstration that the postulated hypothesis was correct was the cure of an HIV-infected individual in Berlin in 2009 who received an allogeneic bone marrow transplant from a donor who lacked the CCR5 chemokine receptor, a naturally arising mutation rendering HIV target cells resistant to infection with macrophage tropic strains of HIV. In 2013, reports were published about a possible cure of HIV-infected individuals who received allogeneic bone marrow transplants with cells not resistant to HIV. We will review these stem cell transplant procedures and discuss their utility to provide a cure for HIV infection, including efficacious future stem cell gene therapy applications.

Original languageEnglish (US)
Pages (from-to)107-116
Number of pages10
JournalExpert Review of Clinical Immunology
Volume10
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Stem Cell Transplantation
HIV Infections
HIV
Stem Cells
Genetic Therapy
Transplants
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cells
Bone Marrow
CCR5 Receptors
Chemokine Receptors
Berlin
Immune System
Macrophages
Safety

Keywords

  • allogeneic bone marrow transplantation for HIV
  • anti-HIV genes
  • bone marrow transplantation
  • CCR5 receptor
  • functional cure for HIV
  • HIV
  • HIV cure
  • stem cell gene therapy for HIV

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Stem cell transplantation in the context of HIV-how can we cure HIV infection? / Bauer, Gerhard; Anderson, Joseph S.

In: Expert Review of Clinical Immunology, Vol. 10, No. 1, 01.2014, p. 107-116.

Research output: Contribution to journalArticle

@article{e8d2b60396564a4ba352fba6324875b7,
title = "Stem cell transplantation in the context of HIV-how can we cure HIV infection?",
abstract = "All HIV target cells are derived from hematopoietic stem cells. More than two decades ago, a hypothesis was postulated that a cure for HIV may be possible by performing a transplant with HIV-resistant hematopoietic stem cells that would allow for an HIV-resistant immune system to arise. HIV-resistant stem cells could be generated by genetically modifying them with gene therapy vectors transferring anti-HIV genes. First attempts of stem cell gene therapy for HIV were carried out in the USA in the 1990s demonstrating safety, but also little efficacy at that time. The first demonstration that the postulated hypothesis was correct was the cure of an HIV-infected individual in Berlin in 2009 who received an allogeneic bone marrow transplant from a donor who lacked the CCR5 chemokine receptor, a naturally arising mutation rendering HIV target cells resistant to infection with macrophage tropic strains of HIV. In 2013, reports were published about a possible cure of HIV-infected individuals who received allogeneic bone marrow transplants with cells not resistant to HIV. We will review these stem cell transplant procedures and discuss their utility to provide a cure for HIV infection, including efficacious future stem cell gene therapy applications.",
keywords = "allogeneic bone marrow transplantation for HIV, anti-HIV genes, bone marrow transplantation, CCR5 receptor, functional cure for HIV, HIV, HIV cure, stem cell gene therapy for HIV",
author = "Gerhard Bauer and Anderson, {Joseph S}",
year = "2014",
month = "1",
doi = "10.1586/1744666X.2014.861326",
language = "English (US)",
volume = "10",
pages = "107--116",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Stem cell transplantation in the context of HIV-how can we cure HIV infection?

AU - Bauer, Gerhard

AU - Anderson, Joseph S

PY - 2014/1

Y1 - 2014/1

N2 - All HIV target cells are derived from hematopoietic stem cells. More than two decades ago, a hypothesis was postulated that a cure for HIV may be possible by performing a transplant with HIV-resistant hematopoietic stem cells that would allow for an HIV-resistant immune system to arise. HIV-resistant stem cells could be generated by genetically modifying them with gene therapy vectors transferring anti-HIV genes. First attempts of stem cell gene therapy for HIV were carried out in the USA in the 1990s demonstrating safety, but also little efficacy at that time. The first demonstration that the postulated hypothesis was correct was the cure of an HIV-infected individual in Berlin in 2009 who received an allogeneic bone marrow transplant from a donor who lacked the CCR5 chemokine receptor, a naturally arising mutation rendering HIV target cells resistant to infection with macrophage tropic strains of HIV. In 2013, reports were published about a possible cure of HIV-infected individuals who received allogeneic bone marrow transplants with cells not resistant to HIV. We will review these stem cell transplant procedures and discuss their utility to provide a cure for HIV infection, including efficacious future stem cell gene therapy applications.

AB - All HIV target cells are derived from hematopoietic stem cells. More than two decades ago, a hypothesis was postulated that a cure for HIV may be possible by performing a transplant with HIV-resistant hematopoietic stem cells that would allow for an HIV-resistant immune system to arise. HIV-resistant stem cells could be generated by genetically modifying them with gene therapy vectors transferring anti-HIV genes. First attempts of stem cell gene therapy for HIV were carried out in the USA in the 1990s demonstrating safety, but also little efficacy at that time. The first demonstration that the postulated hypothesis was correct was the cure of an HIV-infected individual in Berlin in 2009 who received an allogeneic bone marrow transplant from a donor who lacked the CCR5 chemokine receptor, a naturally arising mutation rendering HIV target cells resistant to infection with macrophage tropic strains of HIV. In 2013, reports were published about a possible cure of HIV-infected individuals who received allogeneic bone marrow transplants with cells not resistant to HIV. We will review these stem cell transplant procedures and discuss their utility to provide a cure for HIV infection, including efficacious future stem cell gene therapy applications.

KW - allogeneic bone marrow transplantation for HIV

KW - anti-HIV genes

KW - bone marrow transplantation

KW - CCR5 receptor

KW - functional cure for HIV

KW - HIV

KW - HIV cure

KW - stem cell gene therapy for HIV

UR - http://www.scopus.com/inward/record.url?scp=84893110754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893110754&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2014.861326

DO - 10.1586/1744666X.2014.861326

M3 - Article

VL - 10

SP - 107

EP - 116

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 1

ER -